These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 22466514)

  • 21. Evaluation of Weighted Diffusion Subtraction for Detection of Clinically Significant Prostate Cancer.
    Sato T; Isoda H; Fujimoto K; Furuta A; Fujimoto M; Ito K; Kobayashi T; Nakamoto Y
    J Magn Reson Imaging; 2021 Dec; 54(6):1979-1988. PubMed ID: 34085328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer.
    Haider MA; van der Kwast TH; Tanguay J; Evans AJ; Hashmi AT; Lockwood G; Trachtenberg J
    AJR Am J Roentgenol; 2007 Aug; 189(2):323-8. PubMed ID: 17646457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiparametric 3T MRI for the prediction of pathological downgrading after radical prostatectomy in patients with biopsy-proven Gleason score 3 + 4 prostate cancer.
    Gondo T; Hricak H; Sala E; Zheng J; Moskowitz CS; Bernstein M; Eastham JA; Vargas HA
    Eur Radiol; 2014 Dec; 24(12):3161-70. PubMed ID: 25100337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The clinical value of diffusion-weighted imaging in combination with T2-weighted imaging in diagnosing prostate carcinoma: a systematic review and meta-analysis.
    Wu LM; Xu JR; Ye YQ; Lu Q; Hu JN
    AJR Am J Roentgenol; 2012 Jul; 199(1):103-10. PubMed ID: 22733900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of MRI texture analysis for predicting new Gleason grade group.
    He X; Xiong H; Zhang H; Liu X; Zhou J; Guo D
    Br J Radiol; 2021 May; 94(1121):20210005. PubMed ID: 33684304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiparametric MRI Apparent Diffusion Coefficient (ADC) Accuracy in Diagnosing Clinically Significant Prostate Cancer.
    Pepe P; D'Urso D; Garufi A; Priolo G; Pennisi M; Russo G; Sabini MG; Valastro LM; Galia A; Fraggetta F
    In Vivo; 2017; 31(3):415-418. PubMed ID: 28438871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T2* relaxation time in the detection and assessment of aggressiveness of peripheral zone cancer in comparison with diffusion-weighted imaging.
    Wu LM; Zhou B; Lu Q; Suo ST; Liu Q; Hu J; Haccke EM; Chen XX; Xu JR
    Clin Radiol; 2016 Apr; 71(4):356-62. PubMed ID: 26823021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
    Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
    Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diffusion-weighted imaging for prostate cancer localization: comparison of apparent diffusion coefficient values in cancerous and non-cancerous tissues, and the Gleason score of the radical prostatectomy specimens].
    Kobayashi H; Kitamura K; Mizukami S; Hanazawa K; Sakamoto Y
    Nihon Hinyokika Gakkai Zasshi; 2013 May; 104(3):489-95. PubMed ID: 23819360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results.
    Kim CK; Park BK; Lee HM; Kwon GY
    Invest Radiol; 2007 Dec; 42(12):842-7. PubMed ID: 18007156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extracapsular extension in prostate cancer: added value of diffusion-weighted MRI in patients with equivocal findings on T2-weighted imaging.
    Woo S; Cho JY; Kim SY; Kim SH
    AJR Am J Roentgenol; 2015 Feb; 204(2):W168-75. PubMed ID: 25615777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PI-RADS version 2: quantitative analysis aids reliable interpretation of diffusion-weighted imaging for prostate cancer.
    Park SY; Shin SJ; Jung DC; Cho NH; Choi YD; Rha KH; Hong SJ; Oh YT
    Eur Radiol; 2017 Jul; 27(7):2776-2783. PubMed ID: 27957637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The value of relaxation time quantitative technique from synthetic magnetic resonance imaging in the diagnosis and invasion assessment of prostate cancer].
    Song N; Wang T; Zhang D; Wang Z; Zhang SR; Yu J; Cai L; Ma AL; Zhang Q; Chen ZQ
    Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(15):1093-1099. PubMed ID: 35436808
    [No Abstract]   [Full Text] [Related]  

  • 35. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
    Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
    J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostate MRI: diffusion-weighted imaging at 1.5T correlates better with prostatectomy Gleason Grades than TRUS-guided biopsies in peripheral zone tumours.
    Bittencourt LK; Barentsz JO; de Miranda LC; Gasparetto EL
    Eur Radiol; 2012 Feb; 22(2):468-75. PubMed ID: 21913058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical value of diffusion-weighted magnetic resonance imaging for localization of prostate cancer--comparison with the step sections of radical prostatectomy].
    Hatano K; Tsuda K; Kawamura N; Kakuta Y; Takada T; Adachi S; Hara T; Yamaguchi S
    Nihon Hinyokika Gakkai Zasshi; 2010 May; 101(4):603-8. PubMed ID: 20535988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transition zone prostate cancer: incremental value of diffusion-weighted endorectal MR imaging in tumor detection and assessment of aggressiveness.
    Jung SI; Donati OF; Vargas HA; Goldman D; Hricak H; Akin O
    Radiology; 2013 Nov; 269(2):493-503. PubMed ID: 23878284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Restriction spectrum imaging improves MRI-based prostate cancer detection.
    McCammack KC; Schenker-Ahmed NM; White NS; Best SR; Marks RM; Heimbigner J; Kane CJ; Parsons JK; Kuperman JM; Bartsch H; Desikan RS; Rakow-Penner RA; Liss MA; Margolis DJ; Raman SS; Shabaik A; Dale AM; Karow DS
    Abdom Radiol (NY); 2016 May; 41(5):946-53. PubMed ID: 26910114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and validation of a logistic regression model to distinguish transition zone cancers from benign prostatic hyperplasia on multi-parametric prostate MRI.
    Iyama Y; Nakaura T; Katahira K; Iyama A; Nagayama Y; Oda S; Utsunomiya D; Yamashita Y
    Eur Radiol; 2017 Sep; 27(9):3600-3608. PubMed ID: 28289941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.